Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

Hillmen, P orcid.org/0000-0001-5617-4403, Muus, P, Röth, A et al. (11 more authors) (2013) Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, 162 (1). pp. 62-73. ISSN 0007-1048

Abstract

Metadata

Authors/Creators:
  • Hillmen, P https://orcid.org/0000-0001-5617-4403
  • Muus, P
  • Röth, A
  • Elebute, MO
  • Risitano, AM
  • Schrezenmeier, H
  • Szer, J
  • Browne, P
  • Maciejewski, JP
  • Schubert, J
  • Urbano-Ispizua, A
  • de Castro, C
  • Socié, G
  • Brodsky, RA
Copyright, Publisher and Additional Information: © 2013 John Wiley & Sons Ltd. This article is published open access at https://doi.org/10.1111/bjh.12347.
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Blood Transfusion; Female; Hemoglobins; Hemoglobinuria, Paroxysmal; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Thrombosis; Treatment Outcome; Young Adult; eculizumab; paroxysmal nocturnal haemoglobinuria; phase III; long‐term therapy; haemolysis
Dates:
  • Published: July 2013
  • Accepted: 17 January 2013
  • Published (online): 25 April 2013
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 16 Jul 2019 13:06
Last Modified: 16 Jul 2019 13:06
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/bjh.12347
Related URLs:

Share / Export

Statistics